The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4217287
Max Phase: Preclinical
Molecular Formula: C17H14N4O2S
Molecular Weight: 338.39
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: C/C(=N/N=C1/SCC(=O)N1C(=O)c1ccccc1)c1ccccn1
Standard InChI: InChI=1S/C17H14N4O2S/c1-12(14-9-5-6-10-18-14)19-20-17-21(15(22)11-24-17)16(23)13-7-3-2-4-8-13/h2-10H,11H2,1H3/b19-12-,20-17+
Standard InChI Key: NOXBWWIQOQCMLW-ZNRKNTAXSA-N
Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 338.39Molecular Weight (Monoisotopic): 338.0837AlogP: 2.58#Rotatable Bonds: 3Polar Surface Area: 74.99Molecular Species: NEUTRALHBA: 6HBD: 0#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: 13.24CX Basic pKa: 1.65CX LogP: 2.33CX LogD: 2.33Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.49Np Likeness Score: -1.26
References 1. Carradori S, Bizzarri B, D'Ascenzio M, De Monte C, Grande R, Rivanera D, Zicari A, Mari E, Sabatino M, Patsilinakos A, Ragno R, Secci D.. (2017) Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity., 140 [PMID:28963991 ] [10.1016/j.ejmech.2017.09.026 ]